Macrogol Plus Elektrolyte Dexcel (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 creates an osmotic gradient in the intestinal lumen that draws water into the bowel. The added electrolytes help maintain fluid balance while the increased stool water softens the feces and stimulates peristalsis, facilitating natural bowel movements without systemic absorption.

The appropriate dose is individualized by the prescribing clinician based on the patient’s age, severity of constipation, renal function, and response to therapy. The prescriber will select the volume of oral solution that provides the required amount of macrogol 3350 and electrolytes for each specific case.

Safety data in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified health professional after evaluating the clinical situation.

Enquiries can be submitted through the product page on gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, macrogol 3350 works locally by osmotic water retention rather than stimulating intestinal nerves, resulting in a gentler effect and lower risk of cramping. Unlike bulk‑forming agents, it does not rely on dietary fiber and can be used when fluid intake is limited, while the added electrolytes help prevent imbalances.

Store the oral solution at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture, direct sunlight and extreme temperatures. Do not freeze the solution, and ensure the label remains legible throughout its shelf life.

The product is taken orally as a measured volume of the liquid solution. It should be consumed with a glass of water or other fluid, and the dose may be adjusted by the prescriber according to the patient’s response and clinical needs.

Serious adverse events, although rare, include significant electrolyte disturbances such as hyponatremia or hypokalemia, severe dehydration, and allergic reactions that may present as rash, itching, swelling or anaphylaxis. Prompt medical attention is required if any of these symptoms develop.

The product should be avoided in individuals with known hypersensitivity to macrogol or any of the electrolyte components, in patients with mechanical bowel obstruction, and in those with severe renal impairment where electrolyte handling is compromised. A healthcare professional should assess suitability before initiation.